Preterm birth (delivery before 37 weeks) and low birth weight (LBW, <2,500 g) remain the leading causes of neonatal morbidity and mortality worldwide. Despite advances in obstetric care, rates have not meaningfully declined — in part because a substantial fraction of preterm labor is driven by infection and inflammation that originates far from the cervix.

One of the most consistent, modifiable, and under-screened contributors is periodontal disease. This brief situates the oral-systemic evidence in the preconception window — where it is actionable — and outlines what a salivary pathogen and biomarker read adds to risk stratification before conception.

For the broader context, start with the preconception hub and the oral pathogens clinician brief.

The Oral-Systemic Mechanism

Periodontal disease is not a localized dental problem. It is a chronic, low-grade bacterial infection of the periodontal tissues that seeds the systemic circulation with both live oral pathogens and inflammatory mediators.

Three pathways connect the diseased periodontium to adverse pregnancy outcomes:

1. Hematogenous spread of oral pathogens. Porphyromonas gingivalis, Fusobacterium nucleatum, and Tannerella forsythia enter the bloodstream (bacteremia) during chewing, brushing, and dental procedures. These organisms have been identified in placental tissue, fetal membranes, and amniotic fluid — sites once considered sterile. F. nucleatum in particular is one of the most frequently isolated species from infected amniotic fluid in preterm labor.
2. Inflammatory mediator burden. Periodontal inflammation elevates systemic levels of prostaglandin E2 (PGE2), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) — the same cytokines that drive cervical ripening, membrane weakening, and the onset of labor. A diseased periodontium acts as a remote inflammatory reservoir that lowers the threshold for preterm uterine contractility.
3. Fetal inflammatory response. Once oral pathogens or their virulence factors reach the fetal compartment, they trigger a fetal inflammatory response syndrome (FIRS), which independently predicts preterm delivery, brain injury, and neonatal sepsis.

The Pathogens That Matter

The red-complex trio — P. gingivalis, T. forsythia, and Treponema denticola — together with the bridge pathogen F. nucleatum, carry the strongest evidence for adverse pregnancy outcomes:

• Porphyromonas gingivalis — the keystone pathogen; its virulence factors (gingipains) degrade host defenses and are detectable in placental tissue.
• Fusobacterium nucleatum — the bridge organism; adheres to and invades endothelial cells, facilitating translocation of other pathogens across the placental barrier.
• Tannerella forsythia — a red-complex pathogen associated with severe periodontitis and elevated inflammatory burden.

A high pathogen burden across these organisms in the preconception period is a quantifiable, treatable risk signal — not a wait-and-see finding.

What the Evidence Shows

Meta-analyses of observational studies consistently associate maternal periodontitis with an approximately 1.6–2.0× increased odds of preterm birth and low birth weight. Treatment of periodontal disease during pregnancy has shown variable effect — the evidence is strongest when periodontal therapy is completed before conception, which is precisely why the preconception window matters.

The mechanism is dose-dependent: the higher the pathogen load and inflammatory burden, the higher the risk. This is what makes a quantitative salivary read valuable — it moves the conversation from a binary "gingivitis / no gingivitis" to a measured risk profile you can trend over time.

What a Salivary Read Adds to the Preconception Visit

A preconception salivary pathogen panel measures the oral microbial burden that drives the inflammatory cascade above. For the full biomarker and threshold logic, see the Preconception Salivary Biomarkers guide. In short, it lets you:

• Quantify the pathogen burden of the organisms most strongly linked to preterm labor, rather than relying on a visual periodontal exam alone.
• Stratify patients before conception into low-, moderate-, and high-risk inflammatory profiles.
• Trend the read after periodontal treatment to confirm the burden has actually fallen before a patient conceives.

When to Test, When to Refer

• Test preconception for any patient with a history of periodontal disease, prior preterm birth, recurrent pregnancy loss, or unexplained infertility.
• Test both partners — the male partner's oral pathogen burden is an under-recognized contributor; see the Male-Partner Salivary Testing brief.
• Refer for periodontal therapy when the red-complex or F. nucleatum burden is elevated, and re-test to confirm resolution before conception.
• Walk the full ordering pathway for panel selection, threshold-based interpretation, and re-testing cadence.

The Bottom Line for OB-GYNs and REIs

Periodontal disease is a remote, modifiable inflammatory reservoir that lowers the threshold for preterm labor. Screening and treating it before conception — not after a positive pregnancy test — is where the evidence shows the clearest benefit. A salivary pathogen read turns a historically invisible risk factor into a number you can act on and trend.

---

Continue the path:

← For Clinicians — The Preconception Oral-Systemic Evidence Path

← For Patients — Your Mouth & Your Fertility Journey